Genomma Lab Internacional, S.A.B. de C.V. GNMLF
0.84 USD 0.00 (+0.00%)
At close·Nov 3, 2026, 4:00 PM EST
- YTD
- -21.23%
- 1 year
- -17.33%
Altman Z-Score
2.76 Grey zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
A4 / 5 overall
- DCF 5
- Return on Equity 4
- Return on Assets 4
- Debt / Equity 2
- P/E 4
- P/B 4
P/E 11.6×
P/S 1.1×
P/B 1.7×
P/FCF 22.2×
EV/EBITDA 6.5×
EV/Sales 1.3×
FCF Yield 4.5%
Gross Margin 62.8%
Operating Margin 21.4%
Net Margin 9.2%
ROE 14.5%
ROIC 12.8%
ROA 6.8%
Revenue -5.8%
Operating Income -3.8%
EPS (diluted) 7.8%
Free Cash Flow 769.2%
Current Ratio 1.8×
Quick Ratio 1.4×
Debt / Equity 0.7×
Net Debt / EBITDA 1.3×
Interest Coverage 3.6×
Dividend Yield 4.2%
Payout Ratio 48.4%
Annual · latest fiscal year ends 2025-12-31